{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T05:05:45Z","timestamp":1659589545786},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00213-005-0063-y","type":"journal-article","created":{"date-parts":[[2005,6,30]],"date-time":"2005-06-30T11:29:38Z","timestamp":1120130978000},"page":"95-103","source":"Crossref","is-referenced-by-count":6,"title":["Discriminative stimulus and reinforcing effects of p-fluoro-l-deprenyl in monkeys"],"prefix":"10.1007","volume":"182","author":[{"given":"Sevil","family":"Yasar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozsef","family":"Gaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Justinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,7,1]]},"reference":[{"key":"63_CR1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4088\/JCP.v64n0216","volume":"64","author":"JD Amsterdam","year":"2003","unstructured":"Amsterdam JD (2003) A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder. J Clin Psychiatry 64:208\u2013214","journal-title":"J Clin Psychiatry"},{"key":"63_CR2","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1523\/JNEUROSCI.13-09-04042.1993","volume":"13","author":"KS Ansari","year":"1993","unstructured":"Ansari KS, Yu PH, Kruck TP, Tatton WG (1993) Rescue of axotomized immature rat facial motoneurons by R(\u2212)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J Neurosci 13:4042\u20134053","journal-title":"J Neurosci"},{"key":"63_CR3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0024-3205(93)90251-W","volume":"53","author":"AJ Barber","year":"1993","unstructured":"Barber AJ, Yu PH, Boulton AA (1993) Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice. Life Sci 53:739\u2013747","journal-title":"Life Sci"},{"key":"63_CR4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0893-133X(98)00092-X","volume":"20","author":"G Bartzokis","year":"1999","unstructured":"Bartzokis G, Beckson M, Newton T, Mandelkern M, Mintz J, Foster JA, Ling W, Bridge TP (1999) Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria. Neuropsychopharmacology 20:582\u2013590","journal-title":"Neuropsychopharmacology"},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s002130100890","volume":"159","author":"J Bergman","year":"2001","unstructured":"Bergman J, Yasar S, Winger G (2001) Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors. Psychopharmacology (Berl) 159:21\u201330","journal-title":"Psychopharmacology (Berl)"},{"key":"63_CR6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0301-0082(94)90036-1","volume":"44","author":"MD Berry","year":"1994","unstructured":"Berry MD, Juorio AV, Paterson IA (1994) Possible mechanisms of action of (\u2212)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders. Prog Neurobiol 44:141\u2013161","journal-title":"Prog Neurobiol"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1176\/appi.ajp.159.11.1869","volume":"159","author":"JA Bodkin","year":"2002","unstructured":"Bodkin JA, Amsterdam JD (2002) Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients. Am J Psychiatry 159:1869\u20131875","journal-title":"Am J Psychiatry"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00005053-199605000-00005","volume":"184","author":"JA Bodkin","year":"1996","unstructured":"Bodkin JA, Cohen BM, Salomon MS, Cannon SE, Zornberg GL, Cole JO (1996) Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamine. J Nerv Ment Dis 184:295\u2013301","journal-title":"J Nerv Ment Dis"},{"key":"63_CR9","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/0006-2952(87)90060-8","volume":"36","author":"NT Buu","year":"1987","unstructured":"Buu NT, Angers M (1987) Effects of different monoamine oxidase inhibitors on the metabolism of l-dopa in the rat brain. Biochem Pharmacol 36:1731\u20131735","journal-title":"Biochem Pharmacol"},{"key":"63_CR10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0024-3205(91)90466-O","volume":"48","author":"MC Carrillo","year":"1991","unstructured":"Carrillo MC, Kanai S, Nokubo M, Kitani K (1991) (\u2212) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sci 48:517\u2013521","journal-title":"Life Sci"},{"key":"63_CR11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0014-4886(92)90008-E","volume":"116","author":"MC Carrillo","year":"1992","unstructured":"Carrillo MC, Kanai S, Nokubo M, Ivy GO, Sato Y, Kitani K (1992) (\u2212)Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: the sex and age-related differences in the optimal dose in the rat. Exp Neurol 116:286\u2013294","journal-title":"Exp Neurol"},{"key":"63_CR12","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0006-2952(94)90331-X","volume":"47","author":"MC Carrillo","year":"1994","unstructured":"Carrillo MC, Kitani K, Kanai S, Sato Y, Miyasaka K, Ivy GO (1994) The effect of a long term (6 months) treatment with (\u2212)deprenyl on antioxidant enzyme activities in selective brain regions in old female Fischer 344 rats. Biochem Pharmacol 47:1333\u20131338","journal-title":"Biochem Pharmacol"},{"key":"63_CR13","first-page":"89","volume":"19","author":"G Cohen","year":"1983","unstructured":"Cohen G (1983) The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence. J Neural Transm Suppl 19:89\u2013103","journal-title":"J Neural Transm Suppl"},{"key":"63_CR14","first-page":"125","volume":"79","author":"J Dallo","year":"1992","unstructured":"Dallo J, Knoll J (1992) Effect of (\u2212)-para-fluoro-deprenyl on survival and copulation in male rats. Acta Physiol Hung 79:125\u2013129","journal-title":"Acta Physiol Hung"},{"key":"63_CR15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1037\/0735-7044.117.5.952","volume":"117","author":"P Ciano Di","year":"2003","unstructured":"Di Ciano P, Everitt BJ (2003) Differential control over drug-seeking behavior by drug-associated conditioned reinforcers and discriminative stimuli predictive of drug availability. Behav Neurosci 117:952\u2013960","journal-title":"Behav Neurosci"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1097\/00001756-200008030-00049","volume":"11","author":"F Erdo","year":"2000","unstructured":"Erdo F, Baranyi A, Takacs J, Aranyi P (2000) Different neurorescue profiles of selegiline and p-fluoro-selegiline in gerbils. NeuroReport 11:2597\u20132600","journal-title":"NeuroReport"},{"key":"63_CR17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1212\/WNL.50.3.660","volume":"50","author":"M Freedman","year":"1998","unstructured":"Freedman M, Rewilak D, Xerri T, Cohen S, Gordon AS, Shandling M, Logan AG (1998) l-Deprenyl in Alzheimer's disease: cognitive and behavioral effects. Neurology 50:660\u2013668","journal-title":"Neurology"},{"key":"63_CR18","first-page":"159","volume":"3","author":"RW Fuller","year":"1982","unstructured":"Fuller RW, Hemrick-Luecke SK (1982) Influence of ring and side chain substituents on the selectivity of amphetamine as a monoamine oxidase inhibitor. Res Commun Subst Abuse 3:159","journal-title":"Res Commun Subst Abuse"},{"key":"63_CR19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0028-3908(75)90099-4","volume":"14","author":"RW Fuller","year":"1975","unstructured":"Fuller RW, Baker JC, Perry KW, Molloy BB (1975) Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: drug levels in brain and effects on brain serotonin metabolism. Neuropharmacology 14:739\u2013746","journal-title":"Neuropharmacology"},{"key":"63_CR20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0091-3057(98)00162-2","volume":"62","author":"DL Gelowitz","year":"1999","unstructured":"Gelowitz DL, Paterson IA (1999) Neuronal sparing and behavioral effects of the antiapoptotic drug, (\u2212)deprenyl, following kainic acid administration. Pharmacol Biochem Behav 62:255\u2013262","journal-title":"Pharmacol Biochem Behav"},{"key":"63_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-2999(87)90420-1","volume":"141","author":"CJ Gibson","year":"1987","unstructured":"Gibson CJ (1987) Inhibition of MAO B, but not MAO A, blocks DSP-4 toxicity on central NE neurons. Eur J Pharmacol 141:135\u2013138","journal-title":"Eur J Pharmacol"},{"key":"63_CR22","first-page":"18","volume":"186","author":"SR Goldberg","year":"1973","unstructured":"Goldberg SR (1973) Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey. J Pharmacol Exp Ther 186:18\u201330","journal-title":"J Pharmacol Exp Ther"},{"key":"63_CR23","first-page":"1771","volume":"34","author":"SR Goldberg","year":"1975","unstructured":"Goldberg SR, Kelleher RT, Morse WH (1975) Second-order schedules of drug injection. Fed Proc 34:1771\u20131776","journal-title":"Fed Proc"},{"key":"63_CR24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0028-3908(79)90169-2","volume":"18","author":"SR Goldberg","year":"1979","unstructured":"Goldberg SR, Spealman RD, Kelleher RT (1979) Enhancement of drug-seeking behavior by environmental stimuli associated with cocaine or morphine injections. Neuropharmacology 18:1015\u20131017","journal-title":"Neuropharmacology"},{"key":"63_CR25","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.addbeh.2004.06.018","volume":"29","author":"J Grabowski","year":"2004","unstructured":"Grabowski J, Shearer J, Merrill J, Negus SS (2004) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29:1439\u20131464","journal-title":"Addict Behav"},{"key":"63_CR26","first-page":"581","volume":"202","author":"JA Harvey","year":"1977","unstructured":"Harvey JA, McMaster SE, Fuller RW (1977) Comparison between the neurotoxic and serotonin-depleting effects of various halogenated derivatives of amphetamine in the rat. J Pharmacol Exp Ther 202:581\u2013589","journal-title":"J Pharmacol Exp Ther"},{"key":"63_CR27","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","volume":"224","author":"RE Heikkila","year":"1984","unstructured":"Heikkila RE, Hess A, Duvoisin RC (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224:1451\u20131453","journal-title":"Science"},{"key":"63_CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02257674","volume":"5","author":"EH Heinonen","year":"1993","unstructured":"Heinonen EH, Savijarvi M, Kotila M, Hajba A, Scheinin M (1993) Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease. J Neural Transm Parkinson's Dis Dement Sect 5:193\u2013202","journal-title":"J Neural Transm Parkinson's Dis Dement Sect"},{"key":"63_CR29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-002-1152-9","volume":"163","author":"EJ Houtsmuller","year":"2002","unstructured":"Houtsmuller EJ, Thornton JA, Stitzer ML (2002) Effects of selegiline (l-deprenyl) during smoking and short-term abstinence. Psychopharmacology (Berl) 163:213\u2013220","journal-title":"Psychopharmacology (Berl)"},{"key":"63_CR30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0047-6374(88)90128-5","volume":"46","author":"J Knoll","year":"1988","unstructured":"Knoll J (1988) The striatal dopamine dependency of life span in male rats. Longevity study with (\u2212)deprenyl. Mech Ageing Dev 46:237\u2013262","journal-title":"Mech Ageing Dev"},{"key":"63_CR31","first-page":"393","volume":"5","author":"J Knoll","year":"1972","unstructured":"Knoll J, Magyar K (1972) Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5:393\u2013408","journal-title":"Adv Biochem Psychopharmacol"},{"key":"63_CR32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0047-6374(92)90061-H","volume":"63","author":"J Knoll","year":"1992","unstructured":"Knoll J, Toth V, Kummert M, Sugar J (1992) (\u2212)deprenyl and (\u2212)parafluorodeprenyl-treatment prevents age-related pigment changes in the substantia nigra. A TV-image analysis of neuromelanin. Mech Ageing Dev 63:157\u2013163","journal-title":"Mech Ageing Dev"},{"key":"63_CR33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/BF02532389","volume":"21","author":"A Lajtha","year":"1996","unstructured":"Lajtha A, Sershen H, Cooper T, Hashim A, Gaal J (1996) Metabolism of (\u2212)-deprenyl and PF-(\u2212)-deprenyl in brain after central and peripheral administration. Neurochem Res 21:1155\u20131160","journal-title":"Neurochem Res"},{"key":"63_CR34","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/jpet.104.076554","volume":"312","author":"EL Lane","year":"2005","unstructured":"Lane EL, Cheetham S, Jenner P (2005) Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors. J Pharmacol Exp Ther 312:1124\u20131131","journal-title":"J Pharmacol Exp Ther"},{"key":"63_CR35","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.6332378","volume":"225","author":"JW Langston","year":"1984","unstructured":"Langston JW, Irwin I, Langston EB, Forno LS (1984) Pargyline prevents MPTP-induced parkinsonism in primates. Science 225:1480\u20131482","journal-title":"Science"},{"key":"63_CR36","first-page":"167","volume":"41","author":"K Magyar","year":"1994","unstructured":"Magyar K (1994) Behaviour of (\u2212)-deprenyl and its analogues. J Neural Transm Suppl 41:167\u2013175","journal-title":"J Neural Transm Suppl"},{"key":"63_CR37","first-page":"504","volume":"43","author":"K Magyar","year":"1997","unstructured":"Magyar K (1997) Effect of selegiline against selective neurotoxins. Vopr Med Khim 43:504\u2013514","journal-title":"Vopr Med Khim"},{"key":"63_CR38","first-page":"139","volume":"27","author":"K Magyar","year":"1975","unstructured":"Magyar K, Knoll J (1975) para-Substituted amphetamines and brain serotonin. Pol J Pharmacol Pharm 27:139\u2013143","journal-title":"Pol J Pharmacol Pharm"},{"key":"63_CR39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(95)00478-5","volume":"287","author":"D Marona-Lewicka","year":"1995","unstructured":"Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE (1995) Psychostimulant-like effects of p-fluoroamphetamine in the rat. Eur J Pharmacol 287:105\u2013113","journal-title":"Eur J Pharmacol"},{"key":"63_CR40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0893-133X(00)00206-2","volume":"24","author":"LR McMahon","year":"2001","unstructured":"McMahon LR, Cunningham KA (2001) Role of 5-HT(2a) and 5-HT(2B\/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors. Neuropsychopharmacology 24:319\u2013329","journal-title":"Neuropsychopharmacology"},{"key":"63_CR41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(02)00339-3","volume":"70","author":"SS Negus","year":"2003","unstructured":"Negus SS, Mello NK (2003) Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend 70:39\u201352","journal-title":"Drug Alcohol Depend"},{"key":"63_CR42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-1781(99)00058-X","volume":"87","author":"TF Newton","year":"1999","unstructured":"Newton TF, Kalechstein A, Beckson M, Bartzokis G, Bridge TP, Ling W (1999) Effects of selegiline pretreatment on response to experimental cocaine administration. Psychiatry Res 87:101\u2013106","journal-title":"Psychiatry Res"},{"key":"63_CR43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.npp.1300599","volume":"30","author":"LV Panlilio","year":"2005","unstructured":"Panlilio LV, Yasar S, Nemeth-Coslett R, Katz JL, Henningfield JE, Solinas M, Heishman SJ, Schindler CW, Goldberg SR (2005) Human cocaine-seeking behavior and its control by drug-associated stimuli in the laboratory. Neuropsychopharmacology 30:433\u2013443","journal-title":"Neuropsychopharmacology"},{"key":"63_CR44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0149-7634(96)00008-5","volume":"21","author":"IA Paterson","year":"1997","unstructured":"Paterson IA, Barber AJ, Gelowitz DL, Voll C (1997) (\u2212)Deprenyl reduces delayed neuronal death of hippocampal pyramidal cells. Neurosci Biobehav Rev 21:181\u2013186","journal-title":"Neurosci Biobehav Rev"},{"key":"63_CR45","first-page":"1010","volume":"248","author":"MC Ritz","year":"1989","unstructured":"Ritz MC, Kuhar MJ (1989) Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248:1010\u20131017","journal-title":"J Pharmacol Exp Ther"},{"key":"63_CR46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jnr.490310223","volume":"31","author":"PT Salo","year":"1992","unstructured":"Salo PT, Tatton WG (1992) Deprenyl reduces the death of motoneurons caused by axotomy. J Neurosci Res 31:394\u2013400","journal-title":"J Neurosci Res"},{"key":"63_CR47","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","volume":"336","author":"M Sano","year":"1997","unstructured":"Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 336:1216\u20131222","journal-title":"N Engl J Med"},{"key":"63_CR48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-002-1157-4","volume":"163","author":"CW Schindler","year":"2002","unstructured":"Schindler CW, Panlilio LV, Goldberg SR (2002) Second-order schedules of drug self-administration in animals. Psychopharmacology (Berl) 163:327\u2013344","journal-title":"Psychopharmacology (Berl)"},{"key":"63_CR49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0091-3057(80)90084-2","volume":"13","author":"RS Sloviter","year":"1980","unstructured":"Sloviter RS, Connor JD, Damiano BP, Drust EG (1980) para-Halogenated phenethylamines: similar serotonergic effects in rats by different mechanisms. Pharmacol Biochem Behav 13:283\u2013286","journal-title":"Pharmacol Biochem Behav"},{"key":"63_CR50","first-page":"145","volume":"6","author":"PN Tariot","year":"1998","unstructured":"Tariot PN, Goldstein B, Podgorski CA, Cox C, Frambes N (1998) Short-term administration of selegiline for mild-to-moderate dementia of the Alzheimer's type. Am J Geriatr Psychiatry 6:145\u2013154","journal-title":"Am J Geriatr Psychiatry"},{"key":"63_CR51","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jnr.490300410","volume":"30","author":"WG Tatton","year":"1991","unstructured":"Tatton WG, Greenwood CE (1991) Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism. J Neurosci Res 30:666\u2013672","journal-title":"J Neurosci Res"},{"key":"63_CR52","first-page":"45","volume":"48","author":"WG Tatton","year":"1996","unstructured":"Tatton WG, Wadia JS, Ju WY, Chalmers-Redman RM, Tatton NA (1996) (\u2212)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase. J Neural Transm Suppl 48:45\u201359","journal-title":"J Neural Transm Suppl"},{"key":"63_CR53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1749-6632.1992.tb24584.x","volume":"648","author":"IA Terleckyj","year":"1992","unstructured":"Terleckyj IA, Heikkila RE (1992) In vivo and in vitro pharmacologic profile of two new irreversible MAO-B inhibitors: MDL 72,974A and fluorodeprenyl. Ann NY Acad Sci 648:365\u2013367","journal-title":"Ann NY Acad Sci"},{"key":"63_CR54","first-page":"1163","volume":"285","author":"JW Tidey","year":"1998","unstructured":"Tidey JW, Bergman J (1998) Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther 285:1163\u20131174","journal-title":"J Pharmacol Exp Ther"},{"key":"63_CR55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00008877-199404000-00005","volume":"5","author":"G Winger","year":"1994","unstructured":"Winger G (1994) Dopamine antagonist effects on behavior maintained by cocaine and alfentanil in rhesus monkeys. Behav Pharmacol 5:141\u2013152","journal-title":"Behav Pharmacol"},{"key":"63_CR56","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/clpt.1994.208","volume":"56","author":"GD Winger","year":"1994","unstructured":"Winger GD, Yasar S, Negus SS, Goldberg SR (1994) Intravenous self-administration studies with l-deprenyl (selegiline) in monkeys. Clin Pharmacol Ther 56:774\u2013780","journal-title":"Clin Pharmacol Ther"},{"key":"63_CR57","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/clpt.1994.207","volume":"56","author":"S Yasar","year":"1994","unstructured":"Yasar S, Bergman J (1994) Amphetamine-like effect of l-deprenyl (selegiline) in drug discrimination studies. Clin Pharmacol Ther 56:768\u2013773","journal-title":"Clin Pharmacol Ther"},{"key":"63_CR58","first-page":"A20","volume":"14","author":"S Yasar","year":"2000","unstructured":"Yasar S, Goldberg SR (2000) The antiparkinsonian agent selegiline (l-Deprenyl) maintains moderate rates of i.v. self-administration responding under second-order schedules in squirrel monkeys but does not attenuate the reinforcing effects of amphetamine. J Psychopharmacol 14:A20","journal-title":"J Psychopharmacol"},{"key":"63_CR59","unstructured":"Yasar S, Gaal J, Panlilio LV, Justinova Z, Redhi G, Schindler CW (under review) A comparison of drug-seeking behavior maintained by d-amphetamine, l-deprenyl (selegiline) and d-deprenyl under a second-order schedule in squirrel monkeys. submitted to Psychopharmacology (Berl)"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0063-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-005-0063-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0063-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:31:04Z","timestamp":1558629064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-005-0063-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s00213-005-0063-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,1]]}}}